New Delhi: Panacea Biotec, India’s biggest vaccine manufacturer who
Announcing the commitment, Dr. Rajesh Jain, Jt. Managing Director, Panacea Biotec Ltd said – “We are very happy to extend our continued, unequivocal & unstinted support to GAVI for this noble social cause as developing countries are facing severe challenges in saving children’s lives and protecting people’s health.
The combined demand of all combination pediatric vaccines worldwide is estimated to grow up to USD 1.6 billion by 2012. Pentavalent vaccine market is estimated to cross a mark of USD 1 billion out of which UN agencies are likely to procure vaccines worth more than USD 425 million in 2011.
“Making vaccines affordable as demands grow is the only model which can create sustainable interest with Governments, Donors and other International Agencies to ensure each child is immunized from protectable disease”, said Dr. Rajesh Jain.
Panacea Biotec has a long term agreement with UNICEF to supply 75 million doses for the year 2010, 2011 and 2012.